TRIMscience
Call us Toll-Free at (888) 545-9540
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Acacia 120
Product Overview
Recent Study Results
Secrets of the Acacia
 
TRIMscience
Recent Study Results
 

In a recent eight week clinical study conducted at the University of Connecticut, participants achieved significant results when compared to the placebo in the following areas:

  • Weight Loss (70% greater results than placebo test groups)
  • Fat Loss (92% greater results than placebo test groups)
  • Body Composition Enhancement (121% greater results than placebo test groups)
  • Waist Circumference Reduction (62% greater results than placebo test groups)

Abstract

The influence of a proprietary blend of high viscosity polysaccharides and esterified fatty acids on adipocytokine and regional body composition responses to a weight loss program was examined. Twenty-two women (Supplement group (S) (n=11): age= 36.8±7.2 y; weight=87.4 ±6.1 kg; % body fat= 43.6±7.1); Placebo group (P) (n=11): age = 38.3±6.8 y; weight = 88.3±7.2 kg; % body fat=44.2±8.2) completed an 8-week placebo-controlled, double-blind study consisting of a caloric restricted diet and cardiovascular exercise. Body composition and serum insulin, leptin, and adiponectin were assessed at pre-, mid-, and post- intervention. From pre- to post- intervention, significant decreases (p<0.05) were observed for body weight (S: 87.4±6.1 to 78.2±3.4 kg; P: 88.3±7.2 to 82.9±4.1 kg) (p<0.05 S vs P), % body fat (S: 43.6±7.1 to 36.2±4.4; P: 44.3±8.2 to 40.9±4.3) (p<0.05 S vs P), leptin (S: 28.2±6.1 to 16.3±3.4 µg·ml-1: 29.3±9.1 to 19.7±3.3 µg·ml-1) (p<0.05 S vs P), and insulin (S: 7.2±2.2 to 5.4±2.4 mU·L-1; P: 7.7±2.2 to 5.2±2.7 mU·L-1). Serum adiponectin increased (p<0.05) (S: 12.2±3.1 to 26.2±3.4 µg·ml-1: 12.6±4.2 to 21.7±4.3 µg·ml-1) (p<0.05 for S vs P). Data indicated that supplementation with a proprietary blend of high viscosity polysaccharides and esterified fatty acids during an 8-week weight loss program exhibited favorable effects on adipocytokines and regional body composition.

Introduction

  • Unsuccessful attempts to modulate human obesity have lead to many research attempts to understand the neurological and hormonal pathways regulating energy intake and energy expenditure
  • Adipocytokines appear to play an important role in the connection between the brain, adipose tissue and other peripheral organs involved in the weight regulatory pathway
  • Weight loss programs combining dietary and exercise lifestyle interventions behavior modification and medication appear to be more effective than any these strategies administered alone

Purpose

To determine the effects of a proprietary blend of high viscosity polysaccharides and esterified fatty acids supplementation when combined with an 8-week diet and exercise regimen in women who were overweight on adiposity and adipocytokines

Methods

Participants: 22 healthy women who were overweight Supplement Group (N= 11): Age: 36.8±7.2 y; Height: 163.8±9.1cm Placebo group (N= 11): Age: 38.3±6.8 y; Height: 162.7±9.3 cm

Exercise: 30-60 minutes, 4-5 days/week at 60-90% of max HR Cycling, walking, jogging

Diet: Moderately caloric restricted diet of self-selected commercially available foods in a free-living environment. Weekly nutritional counseling meetings led by a registered dietician.

Supplement: 3 capsules at the two largest meals each day (6 capsules per day) Supplement = 400 mg of high viscosity polysaccharides and Celadrin.

placebo = 400 mg of magnesium stearate per capsule)

Results

Body Mass

Body Mass (kg) during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Body Composition

Body Composition (% Body Fat) during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P <0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Insulin

Circulating Insulin (mU/L) during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Adiponectin

Circulating Adiponectin (µg/ml) during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Leptin

Circulating Leptin (ng/ml) during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Waist Circumference

Waist Circumference (cm) changes during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Hip Circumference

Hip Circumference (cm) changes during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Thigh Circumference

Thigh Circumference (cm) changes during the 8-week weight loss intervention for the supplement and placebo groups. * = P < 0.05 from corresponding Week 0 value. † = P < 0.05 from corresponding Week 4 value. ‡ = P < 0.05 from corresponding Placebo Group value

Conclusion

Both groups of women in the 8-week weight loss program showed:

  • Significant weight and fat loss
  • Significant changes in circulating adipocytokine concentrations

Women receiving the soluble polysaccharide dietary supplement during the weight loss program showed:

  • Greater weight loss
  • Greater fat loss
  • Greater effects on circulating adipocytokine concentrations
 
These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.
Bringing Science to Life
Privacy Policy